GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a prominent focus in healthcare investigation, largely due to its notable impact on treating conditions such as second type diabetes and obesity. Ongoing studies have shown that in addition to glucose regulation, GLP-1 agonists offer benefits for cardiovascular fun